During the past decade, Institut Arnault Tzanck conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Arnault Tzanck" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Zimmer Biomet" with 2 trials sponsored, "Centre Chirurgical Marie Lannelongue" with 1 trials sponsored, "Centre Hospitalier Universitaire de Besancon" with 1 trials sponsored and "Centre Hospitalier Universitaire de Nice" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Arnault Tzanck" #1 collaborator was "Biomet France SARL" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Easy-CRF" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Institut Arnault Tzanck" are "Arthritis" (2 trials), "Ventricular Fibrillation" (2 trials), "Ventricular Tachycardia" (2 trials), "Angioplasty" (1 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "Institut Arnault Tzanck" in a lesser frequency.

Most popular intervention types in "Institut Arnault Tzanck" are "Device" (5 trials), "Other" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "ALK analysis on CTCs detected by ISET" (1 trials), "Endotak Reliance" (1 trials), "IniVAD" (1 trials), "IniVAH" (1 trials) and "Percutaneous MitraClip Device Implantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Arnault Tzanck" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Institut Arnault Tzanck". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Institut Arnault Tzanck, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Arnault Tzanck, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".